Opteon™

Search documents
Truist Raises PT on The Chemours (CC) Stock
Yahoo Finance· 2025-09-24 13:54
Group 1 - The Chemours Company (NYSE:CC) is considered one of the best undervalued stocks to invest in, according to Reddit discussions [1] - Truist raised the price target for Chemours' stock from $18 to $21 while maintaining a "Buy" rating, indicating confidence in the company's future performance [1] - The TiO2 industry is showing signs of pricing discipline and production curtailments, which are expected to contribute to earnings growth for Chemours [1] Group 2 - In Q2 2025, Chemours reported net sales of $1.6 billion, a 4% increase compared to the same quarter last year, driven by a 3% rise in volume and a 1% rise in price [2] - The company's results exceeded expectations, with improvements across all three business segments, supported by strong demand for Opteon™, volume growth in TT, and favorable pricing in APM [2]